Obstructive uropathia in pregnant women: results of treatment depending on the etiopatogenetic factor of development


DOI: https://dx.doi.org/10.18565/urology.2023.6.58-63

Perov R.A., Nemenov A.A., Nizin P.Y., Sokolov N.M., Kotov S.V.

1) N.I. Pirogov Russian National Research Medical University of Ministry of Health of Russia, Department of Urology and Andrology, Moscow, Russia; 2) N.I. Pirogov City Clinical Hospital No. 1 of the Moscow Healthcare Department, Moscow, Russia; 3) University Clinics of Urology, urologic oncology and andrology, SBHI «MMCC «Kommunarka» MHD», Moscow, Russia; 4) S.S. Yudin City Clinical Hospital, Moscow Healthcare Department, Moscow, Russia
Actuality. The development of renal colic in pregnant women is one of the most common reasons for visiting a hospital that is not associated with obstetric pathology. Given the pharmacological and diagnostic limitations during gestation, the problem of expanding the renal cavitary system in pregnant women, as well as the choice of treatment tactics, remains a difficult clinical task.
Materials and methods. The study group included 537 patients with obstructive uropathy with a gestation period of 5 to 36 weeks, who were hospitalized from January 2018 to January 2022 at the GBUZ GKB named after. S.S. Yudina DZM. Depending on the etiopathogenetic obstructive uropathy, the patients were divided into 3 groups: group I – 201 (37.4%) patients with gestational pyelonephritis (the presence of a systemic inflammatory response syndrome) and expansion of the renal cavitary system without confirming the diagnosis of urolithiasis; group II – 216 (40.2%) patients with renal colic (presence of pain without signs of a systemic inflammatory reaction) and enlargement of the renal cavitary system not associated with urolithiasis; group III – 120 (22.4%) pregnant women with an expansion of the cavitary system of the kidney caused by urolithiasis, both with and without signs of a systemic inflammatory reaction. Age, body mass index and previous number of pregnancies in all groups did not differ. The mean age of the patients in the three groups was 26.1 years, with a mean gestational age of 20.8 weeks. In 433 (80.6%) patients, pain was observed in the lumbar region on the right, in 83 (15.5%) – on the left, the bilateral nature of the process – in 21 (3.9%) patients.
Results. In group I, despite ongoing conservative therapy, 129 (64.2%) pregnant women received an internal ureteral stent. After 2–4 weeks of follow-up, the ureteral stent was removed in all patients. As a result, a short-term drainage method (up to 4 weeks) was effective in 90.1% of pregnant women, and in 13 (9.9%) patients, it was necessary to re-insert the stent, followed by a routine replacement of the drain every month. Considering the pain syndrome among patients of group II, drainage was performed in 80 (37%) pregnant women. Routine stent replacement was required in 2 (2.3%) patients. In group III, the location of the calculus in the pyelocaliceal system was in 28 (23.3%) patients, in the ureter - in 92 (76.7%) patients. Independent passage of the calculus was noted in 8 (6.7%) pregnant women, ureteroscopy without prior stenting was performed in 31 (25.8%) pregnant women with ureteral calculus. The remaining 81 (67.5%) pregnant women underwent stent placement at the first stage. When the stone was localized in the ureter, 32 (22.7%) patients underwent contact laser ureterolithotripsy and 21 (17.5%) patients underwent ureterolithoextraction. When a stone was located in the kidney, 28 (23.3%) pregnant women underwent pyelocalicolithotripsy. Achievement of the stone-free status was observed in 92.8%.
Conclusion. Obstructive uropathy in pregnant women requires identification of the cause and a multidisciplinary approach. Long-term drainage of the urinary tract should be avoided and short-term drainage should be preferred. Surgical treatment of urolithiasis, regardless of gestational age, is an effective and safe method.

About the Autors


Corresponding author: R. A. Perov – M.D., candidate of medical science, assistant professor of the department of urology and andrology faculty of medicine, N.I. Pirogov RNRMU, department chief at the City Clinical Hospital named after S.S. Yudin, Moscow, Russia; e-mail: dr.perov@rambler.ru


Similar Articles


Бионика Медиа